Company profile for Ardelyx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are focused on developing and bringing to market first in class medicines to better the lives of underserved patients with cardiorenal diseases. It’s the patients in need that motivate and inspire us to be relentless and work hard every day. They push us to maintain a clear focus on scientific and clinical integrity with a commitment to medical innovation so that we can deliver exceptional medicines. We are committed to ...
We are focused on developing and bringing to market first in class medicines to better the lives of underserved patients with cardiorenal diseases. It’s the patients in need that motivate and inspire us to be relentless and work hard every day. They push us to maintain a clear focus on scientific and clinical integrity with a commitment to medical innovation so that we can deliver exceptional medicines. We are committed to bringing effective medicines to underserved patients by using the gut as the gateway to better health.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
34175 Ardenwood Blvd Suite 200 Fremont, CA 94555
Telephone
Telephone
(510) 745-1700
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/07/3183960/0/en/Real-World-Evidence-Studies-of-XPHOZAH-tenapanor-Demonstrate-Patient-Satisfaction-and-Reduction-in-Serum-Phosphate-with-XPHOZAH-in-Data-Presented-at-ASN-Kidney-Week.html

GLOBENEWSWIRE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181411/0/en/Ardelyx-to-Participate-at-the-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180239/0/en/Ardelyx-President-and-Chief-Executive-Officer-Mike-Raab-to-Participate-in-the-Wedbush-Rewind-American-Society-of-Nephrology-2025-Investor-Conference.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177883/0/en/Ardelyx-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/28/3175386/0/en/Ardelyx-Presents-Data-that-Continues-to-Support-the-Benefits-of-IBSRELA-tenapanor-at-the-American-College-of-Gastroenterology-s-2025-Annual-Meeting.html

GLOBENEWSWIRE
28 Oct 2025

https://www.globenewswire.com/news-release/2025/10/21/3170125/0/en/Ardelyx-Announces-Four-Abstracts-Accepted-for-Poster-Presentations-at-the-American-Society-of-Nephrology-s-Kidney-Week.html

GLOBENEWSWIRE
21 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty